Cargando…

The RSV F p27 peptide: current knowledge, important questions

Respiratory syncytial virus (RSV) remains a leading cause of hospitalizations and death for young children and adults over 65. The worldwide impact of RSV has prioritized the search for an RSV vaccine, with most targeting the critical fusion (F) protein. However, questions remain about the mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rezende, Wanderson, Neal, Hadley E., Dutch, Rebecca E., Piedra, Pedro A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320223/ https://www.ncbi.nlm.nih.gov/pubmed/37415824 http://dx.doi.org/10.3389/fmicb.2023.1219846

Ejemplares similares

Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients
por: Ye, Xunyan, et al.
Publicado: (2020)

The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
por: Cullen, Lori M., et al.
Publicado: (2017)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Acute disseminated encephalomyelitis: current knowledge and open questions
por: Steiner, Israel, et al.
Publicado: (2015)

M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2017)

Two RSV Platforms for G, F, or G+F Proteins VLPs
por: Ha, Binh, et al.
Publicado: (2020)

Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients
por: Ye, Xunyan, et al.
Publicado: (2021)

2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level
por: Comeaux, Christy A, et al.
Publicado: (2022)

Emergence agitation: current knowledge and unresolved questions
por: Lee, Seok-Jin, et al.
Publicado: (2020)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

Non-gradient and genotype-dependent patterns of RSV gene expression
por: Piedra, Felipe-Andrés, et al.
Publicado: (2020)

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
por: Fries, Louis, et al.
Publicado: (2017)

2770. Intrapulmonary Vaccination with an M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against an RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2019)

The Importance of RSV Epidemiological Surveillance: A Multicenter Observational Study of RSV Infection during the COVID-19 Pandemic
por: Pruccoli, Giulia, et al.
Publicado: (2023)

Transient opening of trimeric prefusion RSV F proteins
por: Gilman, Morgan S. A., et al.
Publicado: (2019)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

An Important Question
Publicado: (1875)

Current Insights in the Development of Efficacious Vaccines Against RSV
por: Soto, Jorge A., et al.
Publicado: (2020)

Update on current views and advances on RSV infection (Review)
por: Mammas, Ioannis N., et al.
Publicado: (2020)

RSV Disease: Current Management and the Future of Treatment and Prevention
por: Krilov, Leonard R., et al.
Publicado: (2021)

Extracellular Vesicles from Plants: Current Knowledge and Open Questions
por: Urzì, Ornella, et al.
Publicado: (2021)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
por: Eroglu, Erdal, et al.
Publicado: (2016)

Alternative conformations of a major antigenic site on RSV F
por: Jones, Harrison G., et al.
Publicado: (2019)

Protection of calves by a prefusion-stabilized bovine RSV F vaccine
por: Zhang, Baoshan, et al.
Publicado: (2017)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV
por: Steff, Ann-Muriel, et al.
Publicado: (2017)

2641. Nirsevimab binding-site conservation in RSV F protein between 2015 and 2022: The US OUTSMART-RSV surveillance study
por: Morehouse, Christopher A, et al.
Publicado: (2023)

Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV
por: Sawada, Akihito, et al.
Publicado: (2021)

Fatal RSV in SCID: the Importance of Infection Prevention Despite Newborn Screening
por: Soomann, Maarja, et al.
Publicado: (2023)

Respiratory syncytial virus (RSV): over 60 years of research but still so many unanswered questions
por: Drysdale, Simon B., et al.
Publicado: (2023)

Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection
por: Rajan, Anubama, et al.
Publicado: (2022)

To Be Imported or to Be Endemic? That is the Question
por: Cho, Hae-Wol, et al.
Publicado: (2015)

An Important Question Answered
por: Suess, Henry C.
Publicado: (1885)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus †
por: Joshi, Sameer, et al.
Publicado: (2018)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
por: Rey, Gertrud U., et al.
Publicado: (2013)

Phase 2b Study of an Ad26.RSV.preF Vaccine for Prevention of RSV-mediated Respiratory Tract Disease in Older Adults
por: Falsey, Ann, et al.
Publicado: (2021)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dv00m6pqsa7n75cn2364nocl3p